Table of Contents Chapter 1 Overview of Recombinant Glycosylated Proteins 1.1 Definition of Recombinant Glycosylated Proteins in This Report 1.2 Commercial Types of Recombinant Glycosylated Proteins 1.2.1 Erythropoietin (EPO) 1.2.2 Monoclonal antibodies (mabs) 1.2.3 Follitropin 1.3 Downstream Application of Recombinant Glycosylated Proteins 1.3.1 Oncology 1.3.2 Blood Disorders 1.3.3 Auto-immune Diseases 1.3.4 Infectious disease 1.3.5 Growth Hormone Deficiency 1.4 Development History of Recombinant Glycosylated Proteins 1.5 Market Status and Trend of Recombinant Glycosylated Proteins 2013-2023 1.5.1 Global Recombinant Glycosylated Proteins Market Status and Trend 2013-2023 1.5.2 Regional Recombinant Glycosylated Proteins Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Recombinant Glycosylated Proteins 2013-2017 2.2 Production Market of Recombinant Glycosylated Proteins by Regions 2.2.1 Production Volume of Recombinant Glycosylated Proteins by Regions 2.2.2 Production Value of Recombinant Glycosylated Proteins by Regions 2.3 Demand Market of Recombinant Glycosylated Proteins by Regions 2.4 Production and Demand Status of Recombinant Glycosylated Proteins by Regions 2.4.1 Production and Demand Status of Recombinant Glycosylated Proteins by Regions 2013-2017 2.4.2 Import and Export Status of Recombinant Glycosylated Proteins by Regions 2013-2017 Chapter 3 Global Market Status and Forecast by Types 3.1 Production Volume of Recombinant Glycosylated Proteins by Types 3.2 Production Value of Recombinant Glycosylated Proteins by Types 3.3 Market Forecast of Recombinant Glycosylated Proteins by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Recombinant Glycosylated Proteins by Downstream Industry 4.2 Market Forecast of Recombinant Glycosylated Proteins by Downstream Industry Chapter 5 Market Driving Factor Analysis of Recombinant Glycosylated Proteins 5.1 Global Economy Situation and Trend Overview 5.2 Recombinant Glycosylated Proteins Downstream Industry Situation and Trend Overview Chapter 6 Recombinant Glycosylated Proteins Market Competition Status by Major Manufacturers 6.1 Production Volume of Recombinant Glycosylated Proteins by Major Manufacturers 6.2 Production Value of Recombinant Glycosylated Proteins by Major Manufacturers 6.3 Basic Information of Recombinant Glycosylated Proteins by Major Manufacturers 6.3.1 Headquarters Location and Established Time of Recombinant Glycosylated Proteins Major Manufacturer 6.3.2 Employees and Revenue Level of Recombinant Glycosylated Proteins Major Manufacturer 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Recombinant Glycosylated Proteins Major Manufacturers Introduction and Market Data 7.1 Hospira 7.1.1 Company profile 7.1.2 Representative Recombinant Glycosylated Proteins Product 7.1.3 Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Hospira 7.2 Sandoz International 7.2.1 Company profile 7.2.2 Representative Recombinant Glycosylated Proteins Product 7.2.3 Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Sandoz International 7.3 Teva 7.3.1 Company profile 7.3.2 Representative Recombinant Glycosylated Proteins Product 7.3.3 Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Teva 7.4 Roche 7.4.1 Company profile 7.4.2 Representative Recombinant Glycosylated Proteins Product 7.4.3 Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Roche 7.5 Amgen 7.5.1 Company profile 7.5.2 Representative Recombinant Glycosylated Proteins Product 7.5.3 Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Amgen 7.6 Biocon 7.6.1 Company profile 7.6.2 Representative Recombinant Glycosylated Proteins Product 7.6.3 Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Biocon 7.7 Dr. Reddy's Laboratories 7.7.1 Company profile 7.7.2 Representative Recombinant Glycosylated Proteins Product 7.7.3 Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Dr. Reddy's Laboratories 7.8 Celltrion 7.8.1 Company profile 7.8.2 Representative Recombinant Glycosylated Proteins Product 7.8.3 Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Celltrion 7.9 Mylan 7.9.1 Company profile 7.9.2 Representative Recombinant Glycosylated Proteins Product 7.9.3 Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Mylan 7.10 Actavis 7.10.1 Company profile 7.10.2 Representative Recombinant Glycosylated Proteins Product 7.10.3 Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Actavis 7.11 Merck 7.11.1 Company profile 7.11.2 Representative Recombinant Glycosylated Proteins Product 7.11.3 Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Merck 7.12 Taj Pharmaceuticals 7.12.1 Company profile 7.12.2 Representative Recombinant Glycosylated Proteins Product 7.12.3 Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals Chapter 8 Upstream and Downstream Market Analysis of Recombinant Glycosylated Proteins 8.1 Industry Chain of Recombinant Glycosylated Proteins 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Recombinant Glycosylated Proteins 9.1 Cost Structure Analysis of Recombinant Glycosylated Proteins 9.2 Raw Materials Cost Analysis of Recombinant Glycosylated Proteins 9.3 Labor Cost Analysis of Recombinant Glycosylated Proteins 9.4 Manufacturing Expenses Analysis of Recombinant Glycosylated Proteins Chapter 10 Marketing Status Analysis of Recombinant Glycosylated Proteins 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Erythropoietin (EPO) Table Advantage and Disadvantage of Monoclonal antibodies (mabs) Table Advantage and Disadvantage of Follitropin Table Production Volume of Recombinant Glycosylated Proteins by Regions 2013-2017 Table Production Value of Recombinant Glycosylated Proteins by Regions 2013-2017 Table Demand Volume of Recombinant Glycosylated Proteins by Regions 2013-2017 Table Production and Demand Status of Recombinant Glycosylated Proteins in Region One 2013-2017 Table Production and Demand Status of Recombinant Glycosylated Proteins in Region Two 2013-2017 Table Production and Demand Status of Recombinant Glycosylated Proteins in Region Three 2013-2017 Table Production and Demand Status of Recombinant Glycosylated Proteins in Region Four 2013-2017 Table Import Volume of Recombinant Glycosylated Proteins by Regions 2013-2017 Table Export Volume of Recombinant Glycosylated Proteins by Regions 2013-2017 Table Production Volume of Recombinant Glycosylated Proteins by Types 2013-2017 Table Production Value of Recombinant Glycosylated Proteins by Types 2013-2017 Table Production Volume Forecast of Recombinant Glycosylated Proteins by Types 2018-2023 Table Production Value Forecast of Recombinant Glycosylated Proteins by Types 2018-2023 Table Demand Volume of Recombinant Glycosylated Proteins by Downstream Industry 2013-2017 Table Demand Volume Forecast of Recombinant Glycosylated Proteins by Downstream Industry 2018-2023 Table Production Volume of Recombinant Glycosylated Proteins by Major Manufacturers 2013-2017 Table Production Value of Recombinant Glycosylated Proteins by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Recombinant Glycosylated Proteins Major Manufacturer Table Employees and Revenue Level of Recombinant Glycosylated Proteins Major Manufacturer Table Representative Recombinant Glycosylated Proteins Product One of Hospira Table Representative Recombinant Glycosylated Proteins Product Two of Hospira Table Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Hospira 2013-2017 Table Representative Recombinant Glycosylated Proteins Product One of Sandoz International Table Representative Recombinant Glycosylated Proteins Product Two of Sandoz International Table Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Sandoz International 2013-2017 Table Representative Recombinant Glycosylated Proteins Product One of Teva Table Representative Recombinant Glycosylated Proteins Product Two of Teva Table Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Teva 2013-2017 Table Representative Recombinant Glycosylated Proteins Product One of Roche Table Representative Recombinant Glycosylated Proteins Product Two of Roche Table Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Roche 2013-2017 Table Representative Recombinant Glycosylated Proteins Product One of Amgen Table Representative Recombinant Glycosylated Proteins Product Two of Amgen Table Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Amgen 2013-2017 Table Representative Recombinant Glycosylated Proteins Product One of Biocon Table Representative Recombinant Glycosylated Proteins Product Two of Biocon Table Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Biocon 2013-2017 Table Representative Recombinant Glycosylated Proteins Product One of Dr. Reddy's Laboratories Table Representative Recombinant Glycosylated Proteins Product Two of Dr. Reddy's Laboratories Table Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Dr. Reddy's Laboratories 2013-2017 Table Representative Recombinant Glycosylated Proteins Product One of Celltrion Table Representative Recombinant Glycosylated Proteins Product Two of Celltrion Table Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Celltrion 2013-2017 Table Representative Recombinant Glycosylated Proteins Product One of Mylan Table Representative Recombinant Glycosylated Proteins Product Two of Mylan Table Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Mylan 2013-2017 Table Representative Recombinant Glycosylated Proteins Product One of Actavis Table Representative Recombinant Glycosylated Proteins Product Two of Actavis Table Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Actavis 2013-2017 Table Representative Recombinant Glycosylated Proteins Product One of Merck Table Representative Recombinant Glycosylated Proteins Product Two of Merck Table Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Merck 2013-2017 Table Representative Recombinant Glycosylated Proteins Product One of Taj Pharmaceuticals Table Representative Recombinant Glycosylated Proteins Product Two of Taj Pharmaceuticals Table Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals 2013-2017